ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03456063
Brief Title: A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)

First Submitted : March 5, 2018
First Submitted that Met QC Criteria : March 5, 2018
First Posted : March 7, 2018

Last Update Submitted that Met QC Criteria : September 10, 2018
Last Update Posted : September 11, 2018